Elena Orlando

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
CD20 therapies, CD22 therapies, and combination therapies with a CD...
- Patent number 11,149,076
- Issue date Oct 19, 2021
- Novartis AG
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biomarkers predictive of therapeutic responsiveness to chimeric ant...
- Patent number 10,774,388
- Issue date Sep 15, 2020
- Novartis AG
- Felipe Bedoya
- G01 - MEASURING TESTING
Information Patent Grant
CD20 therapies, CD22 therapies, and combination therapies with a CD...
- Patent number 10,253,086
- Issue date Apr 9, 2019
- Novartis AG
- Hans Bitter
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20230374105
- Publication date Nov 23, 2023
- Novartis AG
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ZBTB32 INHIBITORS AND USES THEREOF
- Publication number 20230332104
- Publication date Oct 19, 2023
- Novartis AG
- Maria ESTEVEZ SILVA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20220195010
- Publication date Jun 23, 2022
- Novartis AG
- Hans Bitter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIOMARKERS FOR EVALUATING CAR-T CELLS TO PREDICT CLINICAL OUTCOME
- Publication number 20210396739
- Publication date Dec 23, 2021
- Novartis AG
- Iulian Pruteanu-Malinici
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPY WITH CHIMERIC ANTIGEN RECEPTOR (CAR) THERAPIES
- Publication number 20210213063
- Publication date Jul 15, 2021
- Novartis AG
- Randi Isaacs
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANT...
- Publication number 20210172020
- Publication date Jun 10, 2021
- Novartis AG
- Felipe Bedoya
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
- Publication number 20200370012
- Publication date Nov 26, 2020
- Novartis AG
- Joseph A. Fraietta
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20190292238
- Publication date Sep 26, 2019
- Novartis AG
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANT...
- Publication number 20170306416
- Publication date Oct 26, 2017
- Felipe Bedoya
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20160362472
- Publication date Dec 15, 2016
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Elena Orlando

Person

Patents Grantslast 30 patents

CD20 therapies, CD22 therapies, and combination therapies with a CD...

Biomarkers predictive of therapeutic responsiveness to chimeric ant...

CD20 therapies, CD22 therapies, and combination therapies with a CD...

Patents Applicationslast 30 patents

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...

ZBTB32 INHIBITORS AND USES THEREOF

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...

BIOMARKERS FOR EVALUATING CAR-T CELLS TO PREDICT CLINICAL OUTCOME

COMBINATION THERAPY WITH CHIMERIC ANTIGEN RECEPTOR (CAR) THERAPIES

BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANT...

METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...

BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANT...

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...